|
Market Closed -
Nasdaq
02:30:00 21/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 515.02 USD | -1.08% |
|
-4.38% | +13.60% |
| Market Cap | 13TCr 12TCr 11TCr 9.98TCr 19TCr 12,09900Cr 20TCr 1,33300Cr 53TCr 6,60500Cr 49TCr 48TCr 20,70200Cr | P/E 2026 * |
35.9x | P/E 2027 * | 29.6x |
|---|---|---|---|---|---|
| Enterprise Value | 13TCr 12TCr 11TCr 9.77TCr 18TCr 11,84400Cr 19TCr 1,30500Cr 52TCr 6,46500Cr 48TCr 47TCr 20,26400Cr | EV / Sales 2026 * |
9.64x | EV / Sales 2027 * | 8.35x |
| Free-Float |
99.73% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VRTX | Delayed | |
| VRTX | Real-time | ||
| VX1 | Real-time | ||
| VX1 | Real-time | ||
| VRTX * | End-of-day quote | ||
| VX1 | Delayed | ||
| VX1 | Delayed | ||
| VX1 | Delayed | ||
| 1VRTX | End-of-day quote | ||
| 0QZU | Delayed | ||
| VRTX | End-of-day quote | ||
| 0QZU | Real-time | ||
| Real-time |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -1.08% | ||
| 1 week | -4.38% | ||
| Current month | -7.85% | ||
| 1 month | -1.81% | ||
| 3 months | -6.03% | ||
| 6 months | +18.79% | ||
| Current year | +13.60% |
| 1 week | 513.8 | 549.56 | |
| 1 month | 509.2 | 568.67 | |
| Current year | 412.27 | 568.67 | |
| 1 year | 412.27 | 568.67 | |
| 3 years | 346.28 | 568.67 | |
| 5 years | 179.96 | 568.67 | |
| 10 years | 71.46 | 568.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 01/04/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 10/04/2019 |
Agam Upadhyay
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 01/01/1998 |
Jeffrey Leiden
CHM | Chairman | 70 | 01/05/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 18/06/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/10/26 | Free | Director | 795 | 0.0003% | ||
| 15/10/26 | Free | Director | 29 | 0.0000% | ||
| 15/10/26 | Free | Director | 93 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.08% | -4.38% | +20.68% | +45.17% | 13TCr | ||
| -0.30% | -6.68% | +27.12% | +127.32% | 1,20000Cr | ||
| +1.25% | -5.35% | +32.65% | +78.98% | 65TCr | ||
| +0.94% | -2.99% | +21.13% | +106.30% | 51TCr | ||
| -0.60% | -1.95% | +25.73% | +67.00% | 38TCr | ||
| +0.69% | -9.50% | +36.78% | +30.83% | 33TCr | ||
| +0.41% | -4.70% | +24.18% | +50.18% | 29TCr | ||
| +0.81% | -4.08% | -2.95% | +31.59% | 27TCr | ||
| -0.15% | -6.45% | +29.06% | +65.76% | 24TCr | ||
| -0.06% | -0.98% | +31.42% | +122.83% | 21TCr | ||
| Average | +0.19% | -4.72% | +24.58% | +72.60% | 42TCr | |
| Weighted average by Cap. | +0.26% | -5.17% | +25.86% | +86.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.33TCr 1.21TCr 1.11TCr 1.01TCr 1.9TCr 1,22800Cr 2TCr 14TCr 5.38TCr 67TCr 4.97TCr 4.87TCr 2,10200Cr | 1.47TCr 1.34TCr 1.23TCr 1.12TCr 2.1TCr 1,35800Cr 2.21TCr 15TCr 5.95TCr 74TCr 5.5TCr 5.38TCr 2,32300Cr |
| Net income | 365.9Cr 333.63Cr 307.19Cr 279.6Cr 524.88Cr 34TCr 552.61Cr 3.74TCr 1.49TCr 19TCr 1.37TCr 1.34TCr 58TCr | 451.86Cr 412.01Cr 379.36Cr 345.28Cr 648.19Cr 42TCr 682.43Cr 4.61TCr 1.83TCr 23TCr 1.7TCr 1.66TCr 72TCr |
| Net Debt | -275.88Cr -251.55Cr -231.61Cr -210.81Cr -395.75Cr -26TCr -416.65Cr -2.82TCr -1.12TCr -14TCr -1.03TCr -1.01TCr -44TCr | -816.21Cr -744.23Cr -685.25Cr -623.7Cr -1.17TCr -76TCr -1.23TCr -8.33TCr -3.31TCr -41TCr -3.06TCr -3TCr -1,29400Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | $515.02 | -1.08% | 17,67,923 |
| 19/26/19 | $520.66 | -2.94% | 11,77,432 |
| 18/26/18 | $536.45 | +0.42% | 12,92,403 |
| 17/26/17 | $534.20 | -0.67% | 15,12,600 |
| 16/26/16 | $537.79 | -0.15% | 12,24,717 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
















